Andes Biotechnologies Global
Founded Year
2008Stage
Seed VC | AliveTotal Raised
$2.17MLast Raised
$2.17M | 6 yrs agoAbout Andes Biotechnologies Global
Andes Biotechnologies is a nucleic acid-based drug discovery and Development Company focused on solid tumor cancers. The company has discovered two novel families of long noncoding RNAs: sense (S-RNA) and antisense noncoding (AS-RNA). Both are present in all human cells, are synthesized in the mitochondria and migrate to the nucleus. The proprietary technology developed by Andes Biotechnologies is based on oligonucleotide therapeutics that target the novel long noncoding regulatory RNA that is present in a variety of cancer indications.
Loading...
Loading...
Andes Biotechnologies Global Patents
Andes Biotechnologies Global has filed 7 patents.
The 3 most popular patent topics include:
- transcription factors
- molecular biology
- oncology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/17/2019 | 5/3/2022 | Antineoplastic drugs, Transcription factors, Experimental cancer drugs, Alkylating antineoplastic agents, Oncology | Grant |
Application Date | 9/17/2019 |
|---|---|
Grant Date | 5/3/2022 |
Title | |
Related Topics | Antineoplastic drugs, Transcription factors, Experimental cancer drugs, Alkylating antineoplastic agents, Oncology |
Status | Grant |
Andes Biotechnologies Global Frequently Asked Questions (FAQ)
When was Andes Biotechnologies Global founded?
Andes Biotechnologies Global was founded in 2008.
Where is Andes Biotechnologies Global's headquarters?
Andes Biotechnologies Global's headquarters is located at Parque Tecnológico Zañartu, Santiago.
What is Andes Biotechnologies Global's latest funding round?
Andes Biotechnologies Global's latest funding round is Seed VC.
How much did Andes Biotechnologies Global raise?
Andes Biotechnologies Global raised a total of $2.17M.
Who are the investors of Andes Biotechnologies Global?
Investors of Andes Biotechnologies Global include Austral Capital and Aurus Ventures.
Loading...
Loading...